Personalized Weight‐Loss Targets for Metabolic Syndrome Reversal: A BMI ‐Normalization Achievement Rate‐Based Cohort Study
Obesity · 2026
DOI: 10.1002/oby.70269 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift Obesity, 2026. Verfasst von Junfeng Qi und 11 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Chronic and Non-Communicable Disease Control and Prevention, Hubei Provincial Center for Disease Control and Prevention, Wuhan, Hubei, C…. Hauptthemen laut MEDLINE: Metabolic Syndrome, Body Mass Index, Weight Loss, Obesity. Die Arbeit nennt 27 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Central Government Transfer Payment for Major Local Public Health Projects: Early Screening and Intervention for High-Risk Populations with Cardiovascular Dise…, Health Commission of Hubei Province, Hubei Provincial Advantaged Characteristic Disciplines (Groups) Project of Wuhan University of Science and Technology.
Abstract (Originalsprache)
Objective
This study aimed to explore personalized weight‐loss targets for metabolic syndrome (MetS) reversal by introducing the BMI‐normalization achievement rate (BMI‐NAR), a novel baseline‐BMI‐scaled metric.
Methods
In a longitudinal cohort of 7340 adults with overweight/obesity and MetS from the ChinaHEART project, BMI‐NAR was defined as the percentage of progress toward a normal BMI (< 24 kg/m 2 ). Logistic regression and restricted cubic splines assessed the dose–response relationship between BMI‐NAR and MetS reversal.
Results
Each 50% increase in BMI‐NAR was significantly associated with MetS reversal (overall: OR = 1.10, 95% CI: 1.07–1.12; overweight: OR = 1.08, 95% CI: 1.06–1.11; obesity: OR = 2.36, 95% CI: 2.00–2.80). The probability of reversal increased steeply beyond exploratory minimum effective thresholds (37% BMI‐NAR for overall; 53% for overweight; 22% for obesity), with benefits observed up to ~165% in the total population, beyond which data were sparse. No clear upper plateau was identified in populations with overweight and obesity. These exploratory thresholds translate into personalized weight‐loss targets: a minimum reduction of 2%–8% for typical overweight (baseline BMI 25–27.99 kg/m 2 ) and 3%–9% for obesity.
Conclusions
MetS reversal does not require full BMI normalization. BMI‐NAR provides a hypothesis‐generating, quantifiable framework for exploring personalized minimum effective weight‐loss goals in this high‐risk population. However, external validation is required before clinical application. image
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Institute of Chronic and Non-Communicable Disease Control and Prevention, Hubei Provincial Center for Disease Control and Prevention, Wuhan, Hubei, China.
- Environmental Toxicology Laboratory, Hubei Province Key Laboratory of Occupational Hazard Identification and Control, School of Public Health, Wuhan University of Science and Technology, Wuhan, Hubei, China.
- Healthy Hubei Development and Social Progress Research Center of the Key Research Base of Humanities and Social Sciences in Hubei Province, School of Public Health, Wuhan University of Science and Technology, Wuhan, Hub…
ORCID-Profile: Xiongfei Pan
Förderung
- Central Government Transfer Payment for Major Local Public Health Projects: Early Screening and Intervention for High-Risk Populations with Cardiovascular Dise…
- Health Commission of Hubei Province
- Hubei Provincial Advantaged Characteristic Disciplines (Groups) Project of Wuhan University of Science and Technology
Zitieren
APA
Qi, J., Xiong, L., Wu, C., Sun, X., Li, J., Ren, L., Yi, C., Shi, Y., Zhang, L., Pan, X., Zhou, T., & Zhu, S. (2026). Personalized Weight‐Loss Targets for Metabolic Syndrome Reversal: A BMI ‐Normalization Achievement Rate‐Based Cohort Study. Obesity. https://doi.org/10.1002/oby.70269
Vancouver
Qi J, Xiong L, Wu C, Sun X, Li J, Ren L, et al. Personalized Weight‐Loss Targets for Metabolic Syndrome Reversal: A BMI ‐Normalization Achievement Rate‐Based Cohort Study. Obesity. 2026. doi:10.1002/oby.70269
BibTeX
@article{Qi2026,
author = {Qi, Junfeng and Xiong, Longzhu and Wu, Chuansha and Sun, Xiaojie and Li, Junlin and Ren, Likun and Yi, Chaoliang and Shi, Yuqin and Zhang, Ling and Pan, Xiongfei and Zhou, Ting and Zhu, Shuzhen},
title = {Personalized Weight‐Loss Targets for Metabolic Syndrome Reversal: A BMI ‐Normalization Achievement Rate‐Based Cohort Study},
journal = {Obesity},
year = {2026},
doi = {10.1002/oby.70269}
}
EUVIMED